Should I buy or sell Sensus Healthcare stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares. View SRTS analyst ratings or view top-rated stocks .

What is Sensus Healthcare's stock price target for 2024?

1 Wall Street research analysts have issued twelve-month price targets for Sensus Healthcare's stock. Their SRTS share price targets range from $7.00 to $8.00. On average, they predict the company's share price to reach $7.50 in the next year. This suggests a possible upside of 128.0% from the stock's current price. View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts .

How have SRTS shares performed in 2024?

Sensus Healthcare's stock was trading at $2.36 at the beginning of 2024. Since then, SRTS shares have increased by 39.4% and is now trading at $3.29. View the best growth stocks for 2024 here .

Are investors shorting Sensus Healthcare?

Sensus Healthcare saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 33,400 shares, a drop of 49.2% from the March 15th total of 65,800 shares. Based on an average trading volume of 162,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.3% of the company's stock are short sold. View Sensus Healthcare's Short Interest .

When is Sensus Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our SRTS earnings forecast .

How can I listen to Sensus Healthcare's earnings call?

Sensus Healthcare will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9785929#".

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its quarterly earnings results on Thursday, February, 8th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.14. The firm earned $12.57 million during the quarter, compared to analysts' expectations of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a trailing twelve-month return on equity of 1.04%.

What guidance has Sensus Healthcare issued on next quarter's earnings?

Sensus Healthcare issued an update on its fourth quarter 2023 earnings guidance on Tuesday, January, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-, compared to the consensus revenue estimate of $7.5 million.

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI) , Sorrento Therapeutics (SRNE) , Corbus Pharmaceuticals (CRBP) , Nabriva Therapeutics (NBRV) , Sangamo Therapeutics (SGMO) , Viking Therapeutics (VKTX) , Vaxart (VXRT) , Amarin (AMRN) , Palatin Technologies (PTN) and QUALCOMM (QCOM) .

When did Sensus Healthcare IPO?

Sensus Healthcare (SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

How do I buy shares of Sensus Healthcare?

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:SRTS

Sensus Healthcare (SRTS) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free SRTS Stock Alerts

$3.29

+0.04 (+1.23%)

(As of 04/19/2024 ET)

Compare

Today's Range: $3.24
▼
$3.39
50-Day Range: $3.14
▼
$4.91
52-Week Range: $1.79
▼
$5.38

Volume: 93,314 shs
Average Volume: 150,962 shs
Market Capitalization: $53.92 million

P/E Ratio: 109.70
Dividend Yield: N/A
Price Target: $7.50

Get Sensus Healthcare alerts:

Sensus Healthcare MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 128.0% Upside
$7.50 Price Target
Short Interest: Healthy
0.26% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.27 out of 5 stars

Medical Sector

365th out of 911 stocks

Surgical & Medical Instruments Industry

41st out of 97 stocks

3.5

Analyst's Opinion

Consensus Rating
Sensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Sensus Healthcare has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.26% of the float of Sensus Healthcare has been sold short.
Short Interest Ratio / Days to Cover
Sensus Healthcare has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Sensus Healthcare has recently decreased by 49.24%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Sensus Healthcare does not currently pay a dividend.
Dividend Growth
Sensus Healthcare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SRTS.

0.0

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Sensus Healthcare this week, compared to 1 article on an average week.
MarketBeat Follows
Only 2 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sensus Healthcare insiders have not sold or bought any company stock.
Percentage Held by Insiders
11.10% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 25.30% of the stock of Sensus Healthcare is held by institutions.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Sensus Healthcare is 109.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 144.43.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sensus Healthcare is 109.70, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 269.39.
Price to Book Value per Share Ratio
Sensus Healthcare has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Sensus Healthcare Stock (NASDAQ:SRTS)

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

SRTS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SRTS Stock News Headlines

April 18, 2024 | globenewswire.com

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

April 11, 2024 | americanbankingnews.com

Sensus Healthcare, Inc. (NASDAQ:SRTS) Short Interest Update

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

March 23, 2024 | wsj.com

Sensus Healthcare Inc.

March 14, 2024 | globenewswire.com

Sensus Healthcare to Participate in the 36th Annual Roth Conference

March 13, 2024 | globenewswire.com

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

March 11, 2024 | realmoney.thestreet.com

A Market With a Hangover

February 25, 2024 | investorplace.com

3 Stocks to Buy That Are Up 100% or More in 2024

April 20, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 24, 2024 | msn.com

Sensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83

February 23, 2024 | benzinga.com

Sensus Healthcare Stock (NASDAQ:SRTS) Earnings Dates and Earning Calls

February 21, 2024 | realmoney.thestreet.com

My Current Game Plan Includes Adding This Small-Cap Stock to My Watch List

February 12, 2024 | finance.yahoo.com

Integer Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?

February 11, 2024 | finance.yahoo.com

Sensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates

February 10, 2024 | markets.businessinsider.com

Sensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy Rating

February 9, 2024 | seekingalpha.com

Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript

February 9, 2024 | finance.yahoo.com

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call Transcript

February 9, 2024 | finance.yahoo.com

Q4 2023 Sensus Healthcare Inc Earnings Call

February 8, 2024 | markets.businessinsider.com

Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results

February 8, 2024 | msn.com

Sensus Healthcare announces U.S. patent for SRT-100 Vision System

February 8, 2024 | finance.yahoo.com

Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities

February 7, 2024 | benzinga.com

Earnings Preview For Sensus Healthcare

February 6, 2024 | finance.yahoo.com

Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements

February 3, 2024 | msn.com

Sensus Healthcare Announces Director Samuel O’Rear’s Retirement

February 2, 2024 | realmoney.thestreet.com

Apple, Amazon and Meta Will Tell Us a Lot About This Market's Health

February 1, 2024 | finance.yahoo.com

Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?

February 1, 2024 | finance.yahoo.com

Sensus Healthcare Announces Retirement of Director Samuel O’Rear

See More Headlines

Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/08/2024
Today: 4/20/2024
Next Earnings (Confirmed): 5/09/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:SRTS
CUSIP: N/A
CIK: 1494891
Web: www.sensushealthcare.com
Phone: (561) 922-5808
Fax: 561-948-2071
Employees: 35
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $7.50
High Stock Price Target: $8.00
Low Stock Price Target: $7.00
Potential Upside/Downside: +128.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.03
Trailing P/E Ratio: 109.70
Forward P/E Ratio: 41.13
P/E Growth: N/A
Net Income: $490,000.00
Net Margins: 1.99%
Pretax Margin: 2.67%
Return on Equity: 1.04%
Return on Assets: 0.93%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 11.76
Quick Ratio: 8.23

Sales & Book Value

Annual Sales: $24.41 million
Price / Sales: 2.21
Cash Flow: $0.06 per share
Price / Cash Flow: 56.28
Book Value: $2.98 per share
Price / Book: 1.10

Miscellaneous

Outstanding Shares: 16,390,000
Free Float: 14,574,000
Market Cap: $53.92 million
Optionable: Optionable
Beta: 0.91

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Joseph C. Sardano (Age 71)
Co-Founder, Chairman & CEO
Comp: $754.43k
Mr. Michael J. Sardano (Age 35)
President, General Counsel, Corporate Secretary & Director
Comp: $404.74k
Mr. Javier Rampolla (Age 51)
Chief Financial Officer
Comp: $439.14k
Ms. Magdalena Martinez (Age 34)
Chief Operating Officer
Mr. Emiliano Sosa (Age 46)
Chief Technology Officer
Sean Delaney
Vice President of Regulatory Affairs & Compliance
Ms. Stephanie Tipton
Vice President of Marketing
Dr. Mark S. Nestor
Medical Director & Member of Medical Advisory Board
Dr. Clay Jefferies Cockerell (Age 67)
Clinical Director & Member of Medical Advisory Board

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SRTS Stock Analysis - Frequently Asked Questions

Should I buy or sell Sensus Healthcare stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares.
View SRTS analyst ratings or view top-rated stocks.
What is Sensus Healthcare's stock price target for 2024?: 1 Wall Street research analysts have issued twelve-month price targets for Sensus Healthcare's stock. Their SRTS share price targets range from $7.00 to $8.00. On average, they predict the company's share price to reach $7.50 in the next year. This suggests a possible upside of 128.0% from the stock's current price.
View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts.
How have SRTS shares performed in 2024?: Sensus Healthcare's stock was trading at $2.36 at the beginning of 2024. Since then, SRTS shares have increased by 39.4% and is now trading at $3.29.
View the best growth stocks for 2024 here.
Are investors shorting Sensus Healthcare?: Sensus Healthcare saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 33,400 shares, a drop of 49.2% from the March 15th total of 65,800 shares. Based on an average trading volume of 162,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.3% of the company's stock are short sold.
View Sensus Healthcare's Short Interest.
When is Sensus Healthcare's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our SRTS earnings forecast.
How can I listen to Sensus Healthcare's earnings call?: Sensus Healthcare will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "9785929#".

How were Sensus Healthcare's earnings last quarter?: Sensus Healthcare, Inc. (NASDAQ:SRTS) posted its quarterly earnings results on Thursday, February, 8th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.14. The firm earned $12.57 million during the quarter, compared to analysts' expectations of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a trailing twelve-month return on equity of 1.04%.
What guidance has Sensus Healthcare issued on next quarter's earnings?: Sensus Healthcare issued an update on its fourth quarter 2023 earnings guidance on Tuesday, January, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-, compared to the consensus revenue estimate of $7.5 million.
What other stocks do shareholders of Sensus Healthcare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).
When did Sensus Healthcare IPO?: Sensus Healthcare (SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.
How do I buy shares of Sensus Healthcare?: Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SRTS) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial